Launch of CE-IVD Marked novel coronavirus test

Paris, France and Camberley, UK – 17 February 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce that its molecular diagnostics division, Primerdesign, has launched its CE-Mark molecular test for the clinical detection of the novel coronavirus (COVID-19).

https://novacyt.com/wp-content/uploads/2020/02/Novacyt-CE-mark-approval-coronavirus-test-ENG.pdf